Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0432222 (
SEM
)
47,337
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Veno-occlusive disease is an important pattern of hepatotoxicity associated with antineoplastic drugs. The study investigated the possible therapeutic effects of
RHS
nanoparticles combined with a PDGF on veno-occlusive disease (VOD) in liver elicited in rats with DAC. In this work, nanosilica (SiO
2
) was successfully prepared from rice husk, and its physicochemical characteristics were investigated using EDX, XRD, N
2
adsorption-desorption isotherm,
SEM
, and TEM. Forty-eight male Sprague-Dawely rats were distributed into 6 groups, with 8 rats in each. The first group served as the control. In the second group, animals were infused with DAC (0.015 mg/kg; 1-3 days) by intraperitoneal injection (i.p.). In the third group, rats were injected i.p. with DAC, and then at 24 h following the last dose of DAC, received nano-
RHS
incorporated with PDGF twice a week for 4 weeks. In the fourth group, normal animals were injected with
RHS
. In the fifth group, normal rats received PDGF, and in the sixth group, normal rats received nano-
RHS
combined with PDGF. The prepared nanosilica showed type II adsorption isotherm characteristic for mesoporous materials with a specific surface area of 236 m
2
/g. TEM imaging confirmed the production of nanoparticles via the followed preparation procedure. Radical scavenging potential for nano-
RHS
was determined using two different in-vitro assays: DPPH, and ABTS radicals. The results of this work show that administration of nano-
RHS
combined with PDGF significantly reversed the oxidative stress effects of DAC as evidenced by a decrease in liver function. It can be concluded that the nano-
RHS
combined with PDGF is useful in preventing oxidative stress and hepatic VOD induced by chemotherapy such as DAC.
...
PMID:Evaluation of the therapeutic effects of rice husk nanosilica combined with platelet-derived growth factor in hepatic veno-occlusive disease. 2930 Oct 90
